Deutsche Bank upgrades Chime Financial stock rating on growth momentum

Deutsche Bank upgraded Chime Financial to Buy from Hold and raised its price target to $35 from $30, implying about 25% upside from $27.93. It lifted fiscal 2027 and 2028 adjusted EBITDA estimates by approximately $71 million to $778 million and $117 million to $1.094 billion, respectively, citing MyPay and Chime Prime growth; it also noted Chime remains unprofitable on a net-income basis. Chime’s agreed $590 million cash acquisition of Stride Bank is expected to close by the first half of 2027, subject to regulatory approval, with $100 million in net synergies cited by BMO Capital.

Analysis

The bullish case is increasingly an execution-and-control story, not just customer growth. Owning the bank could reduce dependence on a partner and give Chime more control over product economics, but it also brings bank-level compliance, capital, and operating obligations. Those costs could absorb part of the stated synergy opportunity; treat the $100 million figure as a target until filings show the scope, timing, and one-time integration costs.

The near-term setup is less attractive than the operating narrative: the shares have already rerated, while the valuation depends on forward adjusted EBITDA rather than net income or demonstrated cash conversion. The key 1–3 month checks are MyPay usage and loss/repayment behavior, customer mix and engagement, and any disclosure of the acquisition’s funding and regulatory milestones. Higher-income customer claims matter only if they improve durable unit economics. Unsecured credit may diversify revenue, but would add consumer-credit and loss-cycle exposure rather than being a free growth option.

Over 6–18 months, successful integration could improve product control and economics; delays, added compliance expense, or weaker-than-expected adoption could instead undermine the multiple. Other digital-finance platforms, including SoFi, may face a stronger competitor if Chime broadens its offering, but the competitive read-through is not yet enough to justify a sector pair. The contrarian risk is that investors capitalize projected EBITDA and synergies before verifying cash generation and bank-level returns.

Key Decisions for Investors

• Avoid chasing CHYM after the rally; consider a staged long only on a pullback or after evidence that MyPay growth is translating into retained engagement and improving unit economics.
• Treat the acquisition as a catalyst watch, not yet a synergy thesis: verify cash funding, regulatory approval timing, integration costs, and the expected path from gross savings to net cash benefit.
• Reassess the bullish thesis if EBITDA guidance is cut, MyPay adoption or repayment quality weakens, or bank integration requires materially higher expense or capital than indicated.
• Do not infer a favorable CHYM-versus-SoFi pair from this item alone; compare valuation, customer economics, and credit exposure before expressing a relative trade.